ACS Chemical Neuroscience

Autism spectrum disorders

In lab research, scientists limit autistic behavior

In a study published this week in ACS Chemical Neuroscience, Saint Louis University researchers report that treating mice with a compound, SR1078, reduces autistic behavior. The drug, developed by Thomas Burris, Ph.D., chair ...

Neuroscience

A brighter future after stroke

There's a stroke every 10 minutes in Canada. Of those, about 10-15 per cent are triggered by arterial ruptures and uncontrolled bleeding in the brain, and are incredibly devastating. These are the strokes that University ...

Psychology & Psychiatry

New study throws into question long-held belief about depression

New evidence puts into doubt the long-standing belief that a deficiency in serotonin—a chemical messenger in the brain—plays a central role in depression. In the journal ACS Chemical Neuroscience, scientists report that ...

Alzheimer's disease & dementia

Toward unraveling the Alzheimer's mystery

Getting to the bottom of Alzheimer's disease has been a rapidly evolving pursuit with many twists, turns and controversies. In the latest crook in the research road, scientists have found a new insight into the interaction ...

Alzheimer's disease & dementia

Researchers find new target for Alzheimer's drug development

Researchers at the University of Minnesota's Center for Drug Design have developed a synthetic compound that, in a mouse model, successfully prevents the neurodegeneration associated with Alzheimer's disease.

Medications

Record 4.02 billion prescriptions in United States in 2011

People in the United States took more prescription drugs than ever last year, with the number of prescriptions increasing from 3.99 billion (with a cost of $308.6 billion) in 2010 to 4.02 billion (with a cost of $319.9 billion) ...

page 5 from 6